Hydrochloric Acid

Hydrochloric Acid

SCHEMBL572631

C=CCc1[nH]cc[n+]1CC=C.[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207289 0.98 KDM4E (0.31) KDM4E
Iodide SCHEMBL4566524 0.96 KDM4E (0.30) KDM4E
Bromide SCHEMBL2439098 0.96 KDM4E (0.30) KDM4E
SCHEMBL6890015 0.91
SCHEMBL19668116 0.91
Thiocyanic Acid SCHEMBL1668413 0.88
SCHEMBL301291 0.88
Sulfurous Acid SCHEMBL17668119 0.88
Acetic Acid SCHEMBL14164758 0.85
SCHEMBL1666245 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120328895-A1 PRE-TREATMENT FOR PRESERVATION OF WOOD EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2012-12-27 US claimed
WO-2012170026-A1 PRE-TREATMENT FOR PRESERVATION OF WOOD EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2012-12-13 WO claimed
US-7951264-B2 Web of papermaking fibers; N-methylmorpholine-N-oxide cellulose solvent; extrude an underivatized cellulosic dope; may be an air-laid or a wet-laid web; sheet may be fabric creped, blade creped, or uncreped GEORGIA-PACIFIC CONSUMER PRODUCTS LP (US) 2011-05-31 US claimed
US-20080173418-A1 Absorbent Cellulosic Products with Regenerated Cellulose Formed In-Situ GEORGIA-PACIFIC CONSUMER PRODUCTS LP (US) 2008-07-24 US claimed
US-4883567-A ELECTRODEPOSITION OF INTERMETALLICS FROM A MELT CONTAINING IMIDAZOLIUM SALT GENERAL MOTORS CORPORATION (US) 1989-11-28 US claimed
US-11981634-B2 Method for preparing fluoroorganic compounds ARKEMA FRANCE (FR) 2024-05-14 US disclosed
CN-113840817-B Process for purifying 1-chloro-3, 3-trifluoropropene 阿科玛法国公司 2024-04-09 CN disclosed
US-11912640-B2 Process for purifying 1-chloro-3,3,3-trifluoropropene ARKEMA FRANCE (FR) 2024-02-27 US disclosed
CN-117209353-A Method for producing 1-chloro-3, 3-trifluoropropene 阿科玛法国公司 2023-12-12 CN disclosed
US-11746073-B2 Method for purifying 1-chloro-3,3,3-trifluoropropene ARKEMA FRANCE (FR) 2023-09-05 US disclosed
CN-112105595-B Method for producing 1-chloro-3, 3-trifluoropropene 阿科玛法国公司 2023-08-15 CN disclosed
US-20230104025-A1 ALUMINUM-ION BATTERY USING ALUMINUM CHLORIDE/TRIMETHYLAMINE IONIC LIQUID AS ELECTROLYTE THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2023-04-06 US disclosed
WO-2004000210-A2 INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC SULFONYLUREIDO PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-31 WO disclosed
EP-1363705-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-11-26 EP disclosed
WO-2003068221-A1 INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC PYRROLIDINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-08-21 WO disclosed
WO-2002062423-A1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-15 WO disclosed
US-6245918-B1 CATALYTIC HYDROGENATION WITH NONAQUEOUS SOLVENT QUATERNARY AMINE SALT; LIQUID AT LOW TEMPERATURES INSTITUT FRANCAIS DU PETROLE (FR) 2001-06-12 US disclosed
US-4883567-A ELECTRODEPOSITION OF INTERMETALLICS FROM A MELT CONTAINING IMIDAZOLIUM SALT GENERAL MOTORS CORPORATION (US) 1989-11-28 US disclosed
US-4883567-A ELECTRODEPOSITION OF INTERMETALLICS FROM A MELT CONTAINING IMIDAZOLIUM SALT GENERAL MOTORS CORPORATION (US) 1989-11-28 US disclosed
US-4463071-A STABILIZATION AGAINST ELECTROCHEMICAL OXIDATION AND REDUCTION ALLIED CORPORATION (US) 1984-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746073-B2 Method for purifying 1-chloro-3,3,3-trifluoropropene HCN1, SFXN1, HCN2 KDM4E 3381/4885
US-11981634-B2 Method for preparing fluoroorganic compounds HCRTR2, NR2C2, NPFFR2 KDM4E 4753/4885
US-11912640-B2 Process for purifying 1-chloro-3,3,3-trifluoropropene CCR1, HCFC1, CXCR1 KDM4E 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.